thiorphan has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stanović, S | 1 |
| Boranić, M | 1 |
| Petrovecki, M | 1 |
| Nemet, D | 1 |
| Skodlar, J | 1 |
| Golubić-Cepulić, B | 1 |
| Batinić, D | 1 |
| Labar, B | 1 |
1 other study available for thiorphan and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Thiorphan stimulates clonal growth of GM-CFU in short-term cultures of bone marrow from a healthy donor and from patients with non-Hodgkin lymphoma.
Topics: Bone Marrow; Cell Division; Cells, Cultured; Colony-Forming Units Assay; Granulocytes; Humans; Lymph | 1998 |